Insulin resistance and nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH)
Wedi'i Gadw mewn:
| Prif Awdur: | |
|---|---|
| Awdur Corfforaethol: | |
| Fformat: | Electronig eLyfr |
| Iaith: | Saesneg |
| Cyhoeddwyd: |
New York :
Nova Biomedical Books,
c2010.
|
| Cyfres: | Metabolic diseases--laboratory and clinical research series.
Novinka (Series) |
| Pynciau: | |
| Mynediad Ar-lein: | An electronic book accessible through the World Wide Web; click to view |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
Tabl Cynhwysion:
- NAFLD and insulin resistance (IR)
- Pathophysiology of NASH : insulin resistance, free fatty acids, and cytokines
- Adiponectin and NASH
- TNF-[alpha] and NAFLD/NASH
- Leptin and NAFLD/NASH
- Peroxisome proliferators-activated receptors (PPARs) and NAFLD/NASH
- Iron overload and NAFLD/NASH
- Mitochondrial abnormalities and NAFLD/NASH
- Genetic influences in NAFLD/NASH
- Therapeutic strategy for NASH patients
- Natural history of NAFLD
- Conclusions.